Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Open Access
- 22 May 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (10), 2261-2271
- https://doi.org/10.1182/bloodadvances.2020001636
Abstract
Key Points. CH is prevalent in patients with angioimmunoblastic T-cell lymphoma.Divergent clonal evolution of CH leads to therapy-related MNs in angioimmunoblaKeywords
This publication has 29 references indexed in Scilit:
- Somatic RHOA mutation in angioimmunoblastic T cell lymphomaNature Genetics, 2014
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics, 2012
- Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parametersBlood, 2012
- IDH2 mutations are frequent in angioimmunoblastic T-cell lymphomaBlood, 2012
- TET2andDNMT3AMutations in Human T-Cell LymphomaNew England Journal of Medicine, 2012
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human LymphomagenesisCancer Cell, 2011
- DNMT3AMutations in Acute Myeloid LeukemiaNew England Journal of Medicine, 2010
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesBlood, 2009
- CHEK2 Is a Multiorgan Cancer Susceptibility GeneAmerican Journal of Human Genetics, 2004